Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341809 · ClinicalTrials.gov registry record
Genetic Analysis of Psoriasis and Psoriatic Arthritis
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,653
- Enrollment target
NCT00341809: Completed study, sponsored by National Cancer Institute (NCI).
NCT00341809 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,653 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341809 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,653 participants
- Enrollment target
Study Summary
This study will examine the genetic basis of psoriasis and psoriatic arthritis. It is known that genes play an important role in determining who gets psoriasis or psoriatic arthritis. This study will look for specific gene variants (alleles) that run in families with these conditions, or are found more often in people with these conditions than in those without them. Participants for this study were identified through the dermatology services of the University of Michigan Medical Center, the Ann Arbor Veterans Affairs Medical Center, the University of Kiel, and Henry Ford Hospital. Additional families were provided by the National Psoriasis Foundation Tissue Bank. They include people with psoriasis or psoriatic arthritis, or both, in addition to some family members of patients. Only families in which the age of the patient at disease onset was below 40 years are included. Patients were included if they had lesions covering more than 1 percent of their total body surface area or if at least two skin, scalp, nail, or joint lesions were diagnosed as psoriasis. Healthy volunteers are also enrolled as control subjects. Participants undergo the following procedures, as follows: Patients with psoriasis and people without psoriasis who have multiple family members with the disease * Skin evaluation * Photographs of lesions for documentation Patients with psoriatic arthritis and people without psoriatic arthritis who have multiple family members with the disease * Joint evaluation and possibly ultrasound * Joint X-rays or review of existing X-rays Patients with psoriasis only, with psoriatic arthritis, and healthy volunteers * Blood draw of 30 milliliters. Some of the blood collected will be used to test for rheumatoid factor and C-reactive protein in patients with psoriatic arthritis. * Periodic questionnaires to update health status information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,653 participants |
| Start Date | 2004-07-30 |
| Est. Completion | 2012-09-04 |
What the finished NCT00341809 record still lists
NCT00341809 is an observational study that tracks outcomes without assigning an intervention. Its 2,653 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00341809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00341809 about?
NCT00341809 is a clinical study titled "Genetic Analysis of Psoriasis and Psoriatic Arthritis". This study will examine the genetic basis of psoriasis and psoriatic arthritis. It is known that genes play an important role in determining who gets psoriasis or psoriatic arthritis. This study will look for specific gene variants (alleles) that run in families with these conditions, or are found m...
What is the current status of trial NCT00341809?
This trial is currently completed. The enrollment target is 2,653 participants. The study started on 2004-07-30. Estimated completion is 2012-09-04.
Who is sponsoring clinical trial NCT00341809?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI